Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shervin Assassi

Showing results (31-40 of 238) with videos related to

Pageof 24
Sort By:
BMC Medicine|January 15, 2013
Genetics of scleroderma: implications for personalized medicine?Shervin Assassi, Timothy R D J Radstake, Maureen D Mayes, et al.
Arthritis and Rheumatism|May 29, 2007
Clinical, immunologic, and genetic features of familial systemic sclerosisShervin Assassi, Frank C Arnett, John D Reveille, et al.
Rheumatology (Oxford, England)|October 14, 2017
Role of STAT3 in skin fibrosis and transforming growth factor beta signallingMesias Pedroza, Sarah To, Shervin Assassi, et al.
Arthritis Care & Research|November 5, 2021
Predictors of Perceived Functional Status in Early Systemic Sclerosis: A Prospective Longitudinal Study of an Early Disease CohortJulia Chernis, Maryam Buni, Sarah Kazzaz, et al.
Arthritis Research & Therapy|January 28, 2023
Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SScChiara Bellocchi, Shervin Assassi, Marka Lyons, et al.
Medicine|August 12, 2022
Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort studyShervin Assassi, Nan Shao, Ziwei Yin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2025
Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic SclerosisShervin Assassi, Christopher P Denton, Matthias Zwick, et al.
EULAR Rheumatology Open|January 9, 2026
Psychometrics of inflammatory back pain criteria in the US populationMark C Hwang, Seokhun Kim, Shervin Assassi, et al.
Current Opinion in Rheumatology|September 20, 2022
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culpritVishal Kakkar, Shervin Assassi, Yannick Allanore, et al.
Arthritis Research & Therapy|April 11, 2023
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitisMark Hwang, Shervin Assassi, Jim Zheng, et al.
Pageof 24

Showing results (31-40 of 238) with videos related to

Sort By:
Pageof 24
BMC Medicine|January 15, 2013
Genetics of scleroderma: implications for personalized medicine?Shervin Assassi, Timothy R D J Radstake, Maureen D Mayes, et al.
Arthritis and Rheumatism|May 29, 2007
Clinical, immunologic, and genetic features of familial systemic sclerosisShervin Assassi, Frank C Arnett, John D Reveille, et al.
Rheumatology (Oxford, England)|October 14, 2017
Role of STAT3 in skin fibrosis and transforming growth factor beta signallingMesias Pedroza, Sarah To, Shervin Assassi, et al.
Arthritis Care & Research|November 5, 2021
Predictors of Perceived Functional Status in Early Systemic Sclerosis: A Prospective Longitudinal Study of an Early Disease CohortJulia Chernis, Maryam Buni, Sarah Kazzaz, et al.
Arthritis Research & Therapy|January 28, 2023
Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SScChiara Bellocchi, Shervin Assassi, Marka Lyons, et al.
Medicine|August 12, 2022
Understanding diagnostic pathways in systemic sclerosis and systemic sclerosis-associated interstitial lung disease: A retrospective cohort studyShervin Assassi, Nan Shao, Ziwei Yin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2025
Peripheral Blood Gene Expression Profiling and Prognostic Significance for the Course of Interstitial Lung Disease in Patients With Systemic SclerosisShervin Assassi, Christopher P Denton, Matthias Zwick, et al.
EULAR Rheumatology Open|January 9, 2026
Psychometrics of inflammatory back pain criteria in the US populationMark C Hwang, Seokhun Kim, Shervin Assassi, et al.
Current Opinion in Rheumatology|September 20, 2022
Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culpritVishal Kakkar, Shervin Assassi, Yannick Allanore, et al.
Arthritis Research & Therapy|April 11, 2023
Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitisMark Hwang, Shervin Assassi, Jim Zheng, et al.
Pageof 24